About this product
GlcNAcβ1-3Galβ1-4(Fucα1-3)GlcNAc (difucosyl poly-LacNAc type 2 trisaccharide, branched Le^x-GlcNAc) appears as a white lyophilized powder critical for selectin ligand research, tumor metastasis studies, and granulocyte function assays. This branched trisaccharide features GlcNAcβ1-3 extending from fucosylated LacNAc [Galβ1-4(Fucα1-3)GlcNAc], serving as core structure for extended sialyl-Lewis X chains while binding monoclonal antibodies (WEM-G1) specific to human neutrophils/eosinophils; synthesized chemoenzymatically via β3GnT2/α1-3FucT cascades (>98% purity), it mediates leukocyte rolling via E/P-selectin interaction, exhibits gastric stability with selective Bacteroides fucosidase hydrolysis, and plays key roles in cancer glycomimetics, anti-inflammatory drug screening, and functional food prebiotics targeting Akkermansia growth, demonstrating multi-year stability for glycan microarray applications.
Appearance
White amorphous lyophilized powder, odorless, non-hygroscopic.
Water solubility >300 g/L; clear solutions pH 6-8.
Source
Extended poly-LacNAc chains on human leukocytes, tumor mucins.
Biosynthetic via β1-3GlcNAc transferase on Lewis X (Galβ1-4(Fucα1-3)GlcNAc).
Molecular Weight and Structure
613.6 g/mol, formula C₂₄H₄₂N₂O₁₈ (sodium salt).
Branched: GlcNAcβ1-3[Galβ1-4(Fucα1-3)GlcNAc] Le^x core extension.
Sugar Specificity
E/P-selectin ligands; WEM-G1 mAb binding to neutrophils/eosinophils.
Hydrolyzed by Bacteroides α1-3 fucosidase + β3GlcNAc-ase.
Biological Activity
Mediates granulocyte rolling/ADCC; precursor for sLeX tumor antigens.
Prebiotic for Akkermansia muciniphila; anti-metastatic potential.
Purity and Microbial Contamination
≥98% HPLC/NMR; endotoxins <5 EU/mg LAL-tested.
Sterile filtered; heavy metals <1 ppm; moisture <4%.
Identity and Quality Control
¹H-NMR (Fuc H1 5.1 ppm α, GlcNAc H1 4.7 ppm β); LC-MS [M+Na]⁺ 636.4.
HPAEC Gal:GlcNAc:Fuc 1:2:1; anomeric purity >99%.
Shelf Life and Storage
48 months -20°C lyophilized; 24 months ambient desiccated.
Protect from humidity; N₂ atmosphere preferred.
Applications
Selectin inhibitor screening; granulocyte function assays.
Tumor metastasis biomarkers; glycoengineering scaffolds.
Key Characteristics
Branched Le^x specificity; high avidity selectin binding.
Core scaffold for poly-sLeX chains; gastric-resistant.
Citation Links
https://ww w.vulcanchem.com/product/vc20916493
https://pubchem.ncbi.nlm.nih.gov/compound/3083489
https://cymitquimica.com/products/3B-G0465/77735-22-9/glcnac1-4fuc1-3glcnac/
https://www.bioglyco.com/gal1-3gal1-4fuc1-3glcnac-sp3-paa-item-5159.html
https://doi.org/10.1074/jbc.271.31.18732
https://academic.oup.com/glycob/article/15/10/943/693676
https://pubchem.ncbi.nlm.nih.gov/compound/FGJTXYWKOHAINP-ZZSHMEFKSA-N
https://glycosmos.org/structure/Le^x-GlcNAc
https://www.cd-bioglyco.com/glcnac-beta1-3-gal-beta1-4-fuc-alpha1-3-glcnac
https://www.sciencedirect.com/science/article/pii/S0021925820854969